PLSE vs ZTS · rev $835.0K vs P/E 25, rev $2.47B
Pulse Biosciences Inc (PLSE) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Pulse Biosciences Inc (PLSE) is a medical instruments & supplies company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported PLSE revenue for 2026-06-30 was $835.0K. Net income was -$43.2M. PLSE currently screens at market cap $1.03B.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
PLSE currently screens at market cap $1.03B. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the PLSE and ZTS stock pages for the full models.
Not investment advice.